Global Therapeutic Protein Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 103551
  • calendar_today Published On: Mar, 2022
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Therapeutic Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Therapeutic Protein market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Pharmaceutical Companies accounting for % of the Therapeutic Protein global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Monoclonal Antibodies segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Therapeutic Protein include Amgen, Abbott Laboratories, AstraZeneca, Baxter International, and Boehringer Ingelheim, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Therapeutic Protein market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Monoclonal Antibodies

Erythropoietin

Insulin

Interferon

Human Growth Hormone

Follicle Stimulating Hormone

Blood Clotting Factors

Market segment by Application can be divided into

Pharmaceutical Companies

Healthcare Service Providers

Research Organizations

Academic Research Institutes

The key market players for global Therapeutic Protein market are listed below:

Amgen

Abbott Laboratories

AstraZeneca

Baxter International

Boehringer Ingelheim

Chugai Pharmaceutical

Diasome Pharmaceuticals

Eli Lilly

GeneScience Pharmaceuticals

Generex Biotechnology

Genentech

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Therapeutic Protein product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Therapeutic Protein, with price, sales, revenue and global market share of Therapeutic Protein from 2019 to 2022.

Chapter 3, the Therapeutic Protein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Therapeutic Protein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Therapeutic Protein market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Therapeutic Protein.

Chapter 13, 14, and 15, to describe Therapeutic Protein sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1 Market Overview

1.1 Therapeutic Protein Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Therapeutic Protein Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Monoclonal Antibodies

1.2.3 Erythropoietin

1.2.4 Insulin

1.2.5 Interferon

1.2.6 Human Growth Hormone

1.2.7 Follicle Stimulating Hormone

1.2.8 Blood Clotting Factors

1.3 Market Analysis by Application

1.3.1 Overview: Global Therapeutic Protein Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 Pharmaceutical Companies

1.3.3 Healthcare Service Providers

1.3.4 Research Organizations

1.3.5 Academic Research Institutes

1.4 Global Therapeutic Protein Market Size & Forecast

1.4.1 Global Therapeutic Protein Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Therapeutic Protein Sales in Volume (2017-2028)

1.4.3 Global Therapeutic Protein Price (2017-2028)

1.5 Global Therapeutic Protein Production Capacity Analysis

1.5.1 Global Therapeutic Protein Total Production Capacity (2017-2028)

1.5.2 Global Therapeutic Protein Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Therapeutic Protein Market Drivers

1.6.2 Therapeutic Protein Market Restraints

1.6.3 Therapeutic Protein Trends Analysis

2 Manufacturers Profiles

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Amgen Details

2.1.2 Amgen Major Business

2.1.3 Amgen Therapeutic Protein Product and Services

2.1.4 Amgen Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Abbott Laboratories

2.2.1 Abbott Laboratories Details

2.2.2 Abbott Laboratories Major Business

2.2.3 Abbott Laboratories Therapeutic Protein Product and Services

2.2.4 Abbott Laboratories Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 AstraZeneca

2.3.1 AstraZeneca Details

2.3.2 AstraZeneca Major Business

2.3.3 AstraZeneca Therapeutic Protein Product and Services

2.3.4 AstraZeneca Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Baxter International

2.4.1 Baxter International Details

2.4.2 Baxter International Major Business

2.4.3 Baxter International Therapeutic Protein Product and Services

2.4.4 Baxter International Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Boehringer Ingelheim

2.5.1 Boehringer Ingelheim Details

2.5.2 Boehringer Ingelheim Major Business

2.5.3 Boehringer Ingelheim Therapeutic Protein Product and Services

2.5.4 Boehringer Ingelheim Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Chugai Pharmaceutical

2.6.1 Chugai Pharmaceutical Details

2.6.2 Chugai Pharmaceutical Major Business

2.6.3 Chugai Pharmaceutical Therapeutic Protein Product and Services

2.6.4 Chugai Pharmaceutical Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 Diasome Pharmaceuticals

2.7.1 Diasome Pharmaceuticals Details

2.7.2 Diasome Pharmaceuticals Major Business

2.7.3 Diasome Pharmaceuticals Therapeutic Protein Product and Services

2.7.4 Diasome Pharmaceuticals Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Eli Lilly

2.8.1 Eli Lilly Details

2.8.2 Eli Lilly Major Business

2.8.3 Eli Lilly Therapeutic Protein Product and Services

2.8.4 Eli Lilly Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 GeneScience Pharmaceuticals

2.9.1 GeneScience Pharmaceuticals Details

2.9.2 GeneScience Pharmaceuticals Major Business

2.9.3 GeneScience Pharmaceuticals Therapeutic Protein Product and Services

2.9.4 GeneScience Pharmaceuticals Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Generex Biotechnology

2.10.1 Generex Biotechnology Details

2.10.2 Generex Biotechnology Major Business

2.10.3 Generex Biotechnology Therapeutic Protein Product and Services

2.10.4 Generex Biotechnology Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Genentech

2.11.1 Genentech Details

2.11.2 Genentech Major Business

2.11.3 Genentech Therapeutic Protein Product and Services

2.11.4 Genentech Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Therapeutic Protein Breakdown Data by Manufacturer

3 Therapeutic Protein Breakdown Data by Manufacturer

3.1 Global Therapeutic Protein Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Therapeutic Protein Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Therapeutic Protein

3.4 Market Concentration Rate

3.4.1 Top 3 Therapeutic Protein Manufacturer Market Share in 2021

3.4.2 Top 6 Therapeutic Protein Manufacturer Market Share in 2021

3.5 Global Therapeutic Protein Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Therapeutic Protein Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4 Market Analysis by Region

4.1 Global Therapeutic Protein Market Size by Region

4.1.1 Global Therapeutic Protein Sales in Volume by Region (2017-2028)

4.1.2 Global Therapeutic Protein Revenue by Region (2017-2028)

4.2 North America Therapeutic Protein Revenue (2017-2028)

4.3 Europe Therapeutic Protein Revenue (2017-2028)

4.4 Asia-Pacific Therapeutic Protein Revenue (2017-2028)

4.5 South America Therapeutic Protein Revenue (2017-2028)

4.6 Middle East and Africa Therapeutic Protein Revenue (2017-2028)

5 Market Segment by Type

5 Market Segment by Type

5.1 Global Therapeutic Protein Sales in Volume by Type (2017-2028)

5.2 Global Therapeutic Protein Revenue by Type (2017-2028)

5.3 Global Therapeutic Protein Price by Type (2017-2028)

6 Market Segment by Application

6 Market Segment by Application

6.1 Global Therapeutic Protein Sales in Volume by Application (2017-2028)

6.2 Global Therapeutic Protein Revenue by Application (2017-2028)

6.3 Global Therapeutic Protein Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7 North America by Country, by Type, and by Application

7.1 North America Therapeutic Protein Sales by Type (2017-2028)

7.2 North America Therapeutic Protein Sales by Application (2017-2028)

7.3 North America Therapeutic Protein Market Size by Country

7.3.1 North America Therapeutic Protein Sales in Volume by Country (2017-2028)

7.3.2 North America Therapeutic Protein Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8 Europe by Country, by Type, and by Application

8.1 Europe Therapeutic Protein Sales by Type (2017-2028)

8.2 Europe Therapeutic Protein Sales by Application (2017-2028)

8.3 Europe Therapeutic Protein Market Size by Country

8.3.1 Europe Therapeutic Protein Sales in Volume by Country (2017-2028)

8.3.2 Europe Therapeutic Protein Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Therapeutic Protein Sales by Type (2017-2028)

9.2 Asia-Pacific Therapeutic Protein Sales by Application (2017-2028)

9.3 Asia-Pacific Therapeutic Protein Market Size by Region

9.3.1 Asia-Pacific Therapeutic Protein Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Therapeutic Protein Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10 South America by Region, by Type, and by Application

10.1 South America Therapeutic Protein Sales by Type (2017-2028)

10.2 South America Therapeutic Protein Sales by Application (2017-2028)

10.3 South America Therapeutic Protein Market Size by Country

10.3.1 South America Therapeutic Protein Sales in Volume by Country (2017-2028)

10.3.2 South America Therapeutic Protein Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Therapeutic Protein Sales by Type (2017-2028)

11.2 Middle East & Africa Therapeutic Protein Sales by Application (2017-2028)

11.3 Middle East & Africa Therapeutic Protein Market Size by Country

11.3.1 Middle East & Africa Therapeutic Protein Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Therapeutic Protein Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12 Raw Material and Industry Chain

12.1 Raw Material of Therapeutic Protein and Key Manufacturers

12.2 Manufacturing Costs Percentage of Therapeutic Protein

12.3 Therapeutic Protein Production Process

12.4 Therapeutic Protein Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Therapeutic Protein Typical Distributors

13.3 Therapeutic Protein Typical Customers

14 Research Findings and Conclusion

14 Research Findings and Conclusion

15 Appendix

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Therapeutic Protein Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Therapeutic Protein Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Amgen Basic Information, Manufacturing Base and Competitors

Table 4. Amgen Major Business

Table 5. Amgen Therapeutic Protein Product and Services

Table 6. Amgen Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors

Table 8. Abbott Laboratories Major Business

Table 9. Abbott Laboratories Therapeutic Protein Product and Services

Table 10. Abbott Laboratories Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors

Table 12. AstraZeneca Major Business

Table 13. AstraZeneca Therapeutic Protein Product and Services

Table 14. AstraZeneca Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Baxter International Basic Information, Manufacturing Base and Competitors

Table 16. Baxter International Major Business

Table 17. Baxter International Therapeutic Protein Product and Services

Table 18. Baxter International Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors

Table 20. Boehringer Ingelheim Major Business

Table 21. Boehringer Ingelheim Therapeutic Protein Product and Services

Table 22. Boehringer Ingelheim Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 24. Chugai Pharmaceutical Major Business

Table 25. Chugai Pharmaceutical Therapeutic Protein Product and Services

Table 26. Chugai Pharmaceutical Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. Diasome Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 28. Diasome Pharmaceuticals Major Business

Table 29. Diasome Pharmaceuticals Therapeutic Protein Product and Services

Table 30. Diasome Pharmaceuticals Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors

Table 32. Eli Lilly Major Business

Table 33. Eli Lilly Therapeutic Protein Product and Services

Table 34. Eli Lilly Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. GeneScience Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 36. GeneScience Pharmaceuticals Major Business

Table 37. GeneScience Pharmaceuticals Therapeutic Protein Product and Services

Table 38. GeneScience Pharmaceuticals Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Generex Biotechnology Basic Information, Manufacturing Base and Competitors

Table 40. Generex Biotechnology Major Business

Table 41. Generex Biotechnology Therapeutic Protein Product and Services

Table 42. Generex Biotechnology Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Genentech Basic Information, Manufacturing Base and Competitors

Table 44. Genentech Major Business

Table 45. Genentech Therapeutic Protein Product and Services

Table 46. Genentech Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Global Therapeutic Protein Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K MT)

Table 48. Global Therapeutic Protein Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 49. Market Position of Manufacturers in Therapeutic Protein, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 50. Global Therapeutic Protein Production Capacity by Company, (K MT): 2020 VS 2021

Table 51. Head Office and Therapeutic Protein Production Site of Key Manufacturer

Table 52. Therapeutic Protein New Entrant and Capacity Expansion Plans

Table 53. Therapeutic Protein Mergers & Acquisitions in the Past Five Years

Table 54. Global Therapeutic Protein Sales by Region (2017-2022) & (K MT)

Table 55. Global Therapeutic Protein Sales by Region (2023-2028) & (K MT)

Table 56. Global Therapeutic Protein Revenue by Region (2017-2022) & (USD Million)

Table 57. Global Therapeutic Protein Revenue by Region (2023-2028) & (USD Million)

Table 58. Global Therapeutic Protein Sales by Type (2017-2022) & (K MT)

Table 59. Global Therapeutic Protein Sales by Type (2023-2028) & (K MT)

Table 60. Global Therapeutic Protein Revenue by Type (2017-2022) & (USD Million)

Table 61. Global Therapeutic Protein Revenue by Type (2023-2028) & (USD Million)

Table 62. Global Therapeutic Protein Price by Type (2017-2022) & (USD/MT)

Table 63. Global Therapeutic Protein Price by Type (2023-2028) & (USD/MT)

Table 64. Global Therapeutic Protein Sales by Application (2017-2022) & (K MT)

Table 65. Global Therapeutic Protein Sales by Application (2023-2028) & (K MT)

Table 66. Global Therapeutic Protein Revenue by Application (2017-2022) & (USD Million)

Table 67. Global Therapeutic Protein Revenue by Application (2023-2028) & (USD Million)

Table 68. Global Therapeutic Protein Price by Application (2017-2022) & (USD/MT)

Table 69. Global Therapeutic Protein Price by Application (2023-2028) & (USD/MT)

Table 70. North America Therapeutic Protein Sales by Country (2017-2022) & (K MT)

Table 71. North America Therapeutic Protein Sales by Country (2023-2028) & (K MT)

Table 72. North America Therapeutic Protein Revenue by Country (2017-2022) & (USD Million)

Table 73. North America Therapeutic Protein Revenue by Country (2023-2028) & (USD Million)

Table 74. North America Therapeutic Protein Sales by Type (2017-2022) & (K MT)

Table 75. North America Therapeutic Protein Sales by Type (2023-2028) & (K MT)

Table 76. North America Therapeutic Protein Sales by Application (2017-2022) & (K MT)

Table 77. North America Therapeutic Protein Sales by Application (2023-2028) & (K MT)

Table 78. Europe Therapeutic Protein Sales by Country (2017-2022) & (K MT)

Table 79. Europe Therapeutic Protein Sales by Country (2023-2028) & (K MT)

Table 80. Europe Therapeutic Protein Revenue by Country (2017-2022) & (USD Million)

Table 81. Europe Therapeutic Protein Revenue by Country (2023-2028) & (USD Million)

Table 82. Europe Therapeutic Protein Sales by Type (2017-2022) & (K MT)

Table 83. Europe Therapeutic Protein Sales by Type (2023-2028) & (K MT)

Table 84. Europe Therapeutic Protein Sales by Application (2017-2022) & (K MT)

Table 85. Europe Therapeutic Protein Sales by Application (2023-2028) & (K MT)

Table 86. Asia-Pacific Therapeutic Protein Sales by Region (2017-2022) & (K MT)

Table 87. Asia-Pacific Therapeutic Protein Sales by Region (2023-2028) & (K MT)

Table 88. Asia-Pacific Therapeutic Protein Revenue by Region (2017-2022) & (USD Million)

Table 89. Asia-Pacific Therapeutic Protein Revenue by Region (2023-2028) & (USD Million)

Table 90. Asia-Pacific Therapeutic Protein Sales by Type (2017-2022) & (K MT)

Table 91. Asia-Pacific Therapeutic Protein Sales by Type (2023-2028) & (K MT)

Table 92. Asia-Pacific Therapeutic Protein Sales by Application (2017-2022) & (K MT)

Table 93. Asia-Pacific Therapeutic Protein Sales by Application (2023-2028) & (K MT)

Table 94. South America Therapeutic Protein Sales by Country (2017-2022) & (K MT)

Table 95. South America Therapeutic Protein Sales by Country (2023-2028) & (K MT)

Table 96. South America Therapeutic Protein Revenue by Country (2017-2022) & (USD Million)

Table 97. South America Therapeutic Protein Revenue by Country (2023-2028) & (USD Million)

Table 98. South America Therapeutic Protein Sales by Type (2017-2022) & (K MT)

Table 99. South America Therapeutic Protein Sales by Type (2023-2028) & (K MT)

Table 100. South America Therapeutic Protein Sales by Application (2017-2022) & (K MT)

Table 101. South America Therapeutic Protein Sales by Application (2023-2028) & (K MT)

Table 102. Middle East & Africa Therapeutic Protein Sales by Region (2017-2022) & (K MT)

Table 103. Middle East & Africa Therapeutic Protein Sales by Region (2023-2028) & (K MT)

Table 104. Middle East & Africa Therapeutic Protein Revenue by Region (2017-2022) & (USD Million)

Table 105. Middle East & Africa Therapeutic Protein Revenue by Region (2023-2028) & (USD Million)

Table 106. Middle East & Africa Therapeutic Protein Sales by Type (2017-2022) & (K MT)

Table 107. Middle East & Africa Therapeutic Protein Sales by Type (2023-2028) & (K MT)

Table 108. Middle East & Africa Therapeutic Protein Sales by Application (2017-2022) & (K MT)

Table 109. Middle East & Africa Therapeutic Protein Sales by Application (2023-2028) & (K MT)

Table 110. Therapeutic Protein Raw Material

Table 111. Key Manufacturers of Therapeutic Protein Raw Materials

Table 112. Direct Channel Pros & Cons

Table 113. Indirect Channel Pros & Cons

Table 114. Therapeutic Protein Typical Distributors

Table 115. Therapeutic Protein Typical Customers

List of Figures

Figure 1. Therapeutic Protein Picture

Figure 2. Global Therapeutic Protein Revenue Market Share by Type in 2021

Figure 3. Monoclonal Antibodies

Figure 4. Erythropoietin

Figure 5. Insulin

Figure 6. Interferon

Figure 7. Human Growth Hormone

Figure 8. Follicle Stimulating Hormone

Figure 9. Blood Clotting Factors

Figure 10. Global Therapeutic Protein Revenue Market Share by Application in 2021

Figure 11. Pharmaceutical Companies

Figure 12. Healthcare Service Providers

Figure 13. Research Organizations

Figure 14. Academic Research Institutes

Figure 15. Global Therapeutic Protein Revenue, (USD Million) & (K MT): 2017 & 2021 & 2028

Figure 16. Global Therapeutic Protein Revenue and Forecast (2017-2028) & (USD Million)

Figure 17. Global Therapeutic Protein Sales (2017-2028) & (K MT)

Figure 18. Global Therapeutic Protein Price (2017-2028) & (USD/MT)

Figure 19. Global Therapeutic Protein Production Capacity (2017-2028) & (K MT)

Figure 20. Global Therapeutic Protein Production Capacity by Geographic Region: 2022 VS 2028

Figure 21. Therapeutic Protein Market Drivers

Figure 22. Therapeutic Protein Market Restraints

Figure 23. Therapeutic Protein Market Trends

Figure 24. Global Therapeutic Protein Sales Market Share by Manufacturer in 2021

Figure 25. Global Therapeutic Protein Revenue Market Share by Manufacturer in 2021

Figure 26. Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 27. Top 3 Therapeutic Protein Manufacturer (Revenue) Market Share in 2021

Figure 28. Top 6 Therapeutic Protein Manufacturer (Revenue) Market Share in 2021

Figure 29. Global Therapeutic Protein Sales Market Share by Region (2017-2028)

Figure 30. Global Therapeutic Protein Revenue Market Share by Region (2017-2028)

Figure 31. North America Therapeutic Protein Revenue (2017-2028) & (USD Million)

Figure 32. Europe Therapeutic Protein Revenue (2017-2028) & (USD Million)

Figure 33. Asia-Pacific Therapeutic Protein Revenue (2017-2028) & (USD Million)

Figure 34. South America Therapeutic Protein Revenue (2017-2028) & (USD Million)

Figure 35. Middle East & Africa Therapeutic Protein Revenue (2017-2028) & (USD Million)

Figure 36. Global Therapeutic Protein Sales Market Share by Type (2017-2028)

Figure 37. Global Therapeutic Protein Revenue Market Share by Type (2017-2028)

Figure 38. Global Therapeutic Protein Price by Type (2017-2028) & (USD/MT)

Figure 39. Global Therapeutic Protein Sales Market Share by Application (2017-2028)

Figure 40. Global Therapeutic Protein Revenue Market Share by Application (2017-2028)

Figure 41. Global Therapeutic Protein Price by Application (2017-2028) & (USD/MT)

Figure 42. North America Therapeutic Protein Sales Market Share by Type (2017-2028)

Figure 43. North America Therapeutic Protein Sales Market Share by Application (2017-2028)

Figure 44. North America Therapeutic Protein Sales Market Share by Country (2017-2028)

Figure 45. North America Therapeutic Protein Revenue Market Share by Country (2017-2028)

Figure 46. United States Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Canada Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Mexico Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 49. Europe Therapeutic Protein Sales Market Share by Type (2017-2028)

Figure 50. Europe Therapeutic Protein Sales Market Share by Application (2017-2028)

Figure 51. Europe Therapeutic Protein Sales Market Share by Country (2017-2028)

Figure 52. Europe Therapeutic Protein Revenue Market Share by Country (2017-2028)

Figure 53. Germany Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. France Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. United Kingdom Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Russia Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Italy Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 58. Asia-Pacific Therapeutic Protein Sales Market Share by Region (2017-2028)

Figure 59. Asia-Pacific Therapeutic Protein Sales Market Share by Application (2017-2028)

Figure 60. Asia-Pacific Therapeutic Protein Sales Market Share by Region (2017-2028)

Figure 61. Asia-Pacific Therapeutic Protein Revenue Market Share by Region (2017-2028)

Figure 62. China Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Japan Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. Korea Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. India Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Southeast Asia Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. Australia Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 68. South America Therapeutic Protein Sales Market Share by Type (2017-2028)

Figure 69. South America Therapeutic Protein Sales Market Share by Application (2017-2028)

Figure 70. South America Therapeutic Protein Sales Market Share by Country (2017-2028)

Figure 71. South America Therapeutic Protein Revenue Market Share by Country (2017-2028)

Figure 72. Brazil Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Argentina Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 74. Middle East & Africa Therapeutic Protein Sales Market Share by Type (2017-2028)

Figure 75. Middle East & Africa Therapeutic Protein Sales Market Share by Application (2017-2028)

Figure 76. Middle East & Africa Therapeutic Protein Sales Market Share by Region (2017-2028)

Figure 77. Middle East & Africa Therapeutic Protein Revenue Market Share by Region (2017-2028)

Figure 78. Turkey Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Egypt Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. Saudi Arabia Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. South Africa Therapeutic Protein Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 82. Manufacturing Cost Structure Analysis of Therapeutic Protein in 2021

Figure 83. Manufacturing Process Analysis of Therapeutic Protein

Figure 84. Therapeutic Protein Industrial Chain

Figure 85. Sales Channel: Direct Channel vs Indirect Channel

Figure 86. Methodology

Figure 87. Research Process and Data Source